 | • レポートコード：MRC2-11QY00387 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は認知・記憶増強薬のグローバル市場について調査・分析したレポートです。種類別（アリセプト、エクセロン、ナメンダ、ラザダイン、プロビジル、リタリン、アデロール、その他）市場規模、用途別（疾病治療、学業成績、運動能力、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別認知・記憶増強薬の競争状況、市場シェア ・世界の認知・記憶増強薬市場：種類別市場規模 2015年-2020年（アリセプト、エクセロン、ナメンダ、ラザダイン、プロビジル、リタリン、アデロール、その他） ・世界の認知・記憶増強薬市場：種類別市場規模予測 2021年-2026年（アリセプト、エクセロン、ナメンダ、ラザダイン、プロビジル、リタリン、アデロール、その他） ・世界の認知・記憶増強薬市場：用途別市場規模 2015年-2020年（疾病治療、学業成績、運動能力、その他） ・世界の認知・記憶増強薬市場：用途別市場規模予測 2021年-2026年（疾病治療、学業成績、運動能力、その他） ・北米の認知・記憶増強薬市場分析：米国、カナダ ・ヨーロッパの認知・記憶増強薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの認知・記憶増強薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の認知・記憶増強薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの認知・記憶増強薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Eisai Co、Allergan、Novartis、Takeda、Johnson & Johnson、Takeda Pharmaceutical Company Limited、AlternaScript、Cephalon、Ceretropic ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cognitive enhancers are drugs and supplements, which are majorly used to treat patients suffering from Alzheimer’s disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging.
In 2017, the global Cognitive and Memory Enhancer Drugs market size was 4130 million US$ and is forecast to 8030 million US in 2025, growing at a CAGR of 8.7% from 2018. The objectives of this study are to define, segment, and project the size of the Cognitive and Memory Enhancer Drugs market based on company, product type, application and key regions.
Market Analysis and Insights: Global Cognitive and Memory Enhancer Drugs Market
The global Cognitive and Memory Enhancer Drugs market size is projected to reach US$ 4270.4 million by 2026, from US$ 4056.6 million in 2020, at a CAGR of 4.9%% during 2021-2026.
Global Cognitive and Memory Enhancer Drugs Scope and Market Size
Cognitive and Memory Enhancer Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cognitive and Memory Enhancer Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cognitive and Memory Enhancer Drugs market is segmented into
Aricept
Exelon
Namenda
Razadyne
Provigil
Ritalin
Adderall
Others
Segment by Application, the Cognitive and Memory Enhancer Drugs market is segmented into
Disease Treatment
Academic Performance
Athletic Performance
Others
Regional and Country-level Analysis
The Cognitive and Memory Enhancer Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cognitive and Memory Enhancer Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cognitive and Memory Enhancer Drugs Market Share Analysis
Cognitive and Memory Enhancer Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cognitive and Memory Enhancer Drugs business, the date to enter into the Cognitive and Memory Enhancer Drugs market, Cognitive and Memory Enhancer Drugs product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Eisai Co
Allergan
Novartis
Takeda
Johnson & Johnson
Takeda Pharmaceutical Company Limited
AlternaScript
Cephalon
Ceretropic
1 Study Coverage
1.1 Cognitive and Memory Enhancer Drugs Product Introduction
1.2 Market Segments
1.3 Key Cognitive and Memory Enhancer Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Type
1.4.2 Aricept
1.4.3 Exelon
1.4.4 Namenda
1.4.5 Razadyne
1.4.6 Provigil
1.4.7 Ritalin
1.4.8 Adderall
1.4.9 Others
1.5 Market by Application
1.5.1 Global Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Application
1.5.2 Disease Treatment
1.5.3 Academic Performance
1.5.4 Athletic Performance
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Cognitive and Memory Enhancer Drugs Market Size, Estimates and Forecasts
2.1.1 Global Cognitive and Memory Enhancer Drugs Revenue 2015-2026
2.1.2 Global Cognitive and Memory Enhancer Drugs Sales 2015-2026
2.2 Global Cognitive and Memory Enhancer Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Cognitive and Memory Enhancer Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Cognitive and Memory Enhancer Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cognitive and Memory Enhancer Drugs Competitor Landscape by Players
3.1 Cognitive and Memory Enhancer Drugs Sales by Manufacturers
3.1.1 Cognitive and Memory Enhancer Drugs Sales by Manufacturers (2015-2020)
3.1.2 Cognitive and Memory Enhancer Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Cognitive and Memory Enhancer Drugs Revenue by Manufacturers
3.2.1 Cognitive and Memory Enhancer Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Cognitive and Memory Enhancer Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cognitive and Memory Enhancer Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Cognitive and Memory Enhancer Drugs Revenue in 2019
3.2.5 Global Cognitive and Memory Enhancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Cognitive and Memory Enhancer Drugs Price by Manufacturers
3.4 Cognitive and Memory Enhancer Drugs Manufacturing Base Distribution, Product Types
3.4.1 Cognitive and Memory Enhancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cognitive and Memory Enhancer Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Cognitive and Memory Enhancer Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cognitive and Memory Enhancer Drugs Market Size by Type (2015-2020)
4.1.1 Global Cognitive and Memory Enhancer Drugs Sales by Type (2015-2020)
4.1.2 Global Cognitive and Memory Enhancer Drugs Revenue by Type (2015-2020)
4.1.3 Cognitive and Memory Enhancer Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Cognitive and Memory Enhancer Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Cognitive and Memory Enhancer Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Cognitive and Memory Enhancer Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Cognitive and Memory Enhancer Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Cognitive and Memory Enhancer Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Cognitive and Memory Enhancer Drugs Market Size by Application (2015-2020)
5.1.1 Global Cognitive and Memory Enhancer Drugs Sales by Application (2015-2020)
5.1.2 Global Cognitive and Memory Enhancer Drugs Revenue by Application (2015-2020)
5.1.3 Cognitive and Memory Enhancer Drugs Price by Application (2015-2020)
5.2 Cognitive and Memory Enhancer Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Cognitive and Memory Enhancer Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Cognitive and Memory Enhancer Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Cognitive and Memory Enhancer Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Cognitive and Memory Enhancer Drugs by Country
6.1.1 North America Cognitive and Memory Enhancer Drugs Sales by Country
6.1.2 North America Cognitive and Memory Enhancer Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Cognitive and Memory Enhancer Drugs Market Facts & Figures by Type
6.3 North America Cognitive and Memory Enhancer Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Cognitive and Memory Enhancer Drugs by Country
7.1.1 Europe Cognitive and Memory Enhancer Drugs Sales by Country
7.1.2 Europe Cognitive and Memory Enhancer Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Cognitive and Memory Enhancer Drugs Market Facts & Figures by Type
7.3 Europe Cognitive and Memory Enhancer Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Cognitive and Memory Enhancer Drugs by Region
8.1.1 Asia Pacific Cognitive and Memory Enhancer Drugs Sales by Region
8.1.2 Asia Pacific Cognitive and Memory Enhancer Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Cognitive and Memory Enhancer Drugs Market Facts & Figures by Type
8.3 Asia Pacific Cognitive and Memory Enhancer Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Cognitive and Memory Enhancer Drugs by Country
9.1.1 Latin America Cognitive and Memory Enhancer Drugs Sales by Country
9.1.2 Latin America Cognitive and Memory Enhancer Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Cognitive and Memory Enhancer Drugs Market Facts & Figures by Type
9.3 Central & South America Cognitive and Memory Enhancer Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Cognitive and Memory Enhancer Drugs by Country
10.1.1 Middle East and Africa Cognitive and Memory Enhancer Drugs Sales by Country
10.1.2 Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Cognitive and Memory Enhancer Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Cognitive and Memory Enhancer Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Cognitive and Memory Enhancer Drugs Products Offered
11.1.5 Pfizer Related Developments
11.2 Eisai Co
11.2.1 Eisai Co Corporation Information
11.2.2 Eisai Co Description and Business Overview
11.2.3 Eisai Co Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eisai Co Cognitive and Memory Enhancer Drugs Products Offered
11.2.5 Eisai Co Related Developments
11.3 Allergan
11.3.1 Allergan Corporation Information
11.3.2 Allergan Description and Business Overview
11.3.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Allergan Cognitive and Memory Enhancer Drugs Products Offered
11.3.5 Allergan Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description and Business Overview
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Cognitive and Memory Enhancer Drugs Products Offered
11.4.5 Novartis Related Developments
11.5 Takeda
11.5.1 Takeda Corporation Information
11.5.2 Takeda Description and Business Overview
11.5.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Takeda Cognitive and Memory Enhancer Drugs Products Offered
11.5.5 Takeda Related Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description and Business Overview
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Cognitive and Memory Enhancer Drugs Products Offered
11.6.5 Johnson & Johnson Related Developments
11.7 Takeda Pharmaceutical Company Limited
11.7.1 Takeda Pharmaceutical Company Limited Corporation Information
11.7.2 Takeda Pharmaceutical Company Limited Description and Business Overview
11.7.3 Takeda Pharmaceutical Company Limited Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Products Offered
11.7.5 Takeda Pharmaceutical Company Limited Related Developments
11.8 AlternaScript
11.8.1 AlternaScript Corporation Information
11.8.2 AlternaScript Description and Business Overview
11.8.3 AlternaScript Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AlternaScript Cognitive and Memory Enhancer Drugs Products Offered
11.8.5 AlternaScript Related Developments
11.9 Cephalon
11.9.1 Cephalon Corporation Information
11.9.2 Cephalon Description and Business Overview
11.9.3 Cephalon Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Cephalon Cognitive and Memory Enhancer Drugs Products Offered
11.9.5 Cephalon Related Developments
11.10 Ceretropic
11.10.1 Ceretropic Corporation Information
11.10.2 Ceretropic Description and Business Overview
11.10.3 Ceretropic Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Ceretropic Cognitive and Memory Enhancer Drugs Products Offered
11.10.5 Ceretropic Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Cognitive and Memory Enhancer Drugs Products Offered
11.1.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Cognitive and Memory Enhancer Drugs Market Estimates and Projections by Region
12.1.1 Global Cognitive and Memory Enhancer Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Cognitive and Memory Enhancer Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Cognitive and Memory Enhancer Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Cognitive and Memory Enhancer Drugs Sales Forecast (2021-2026)
12.2.2 North America: Cognitive and Memory Enhancer Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Cognitive and Memory Enhancer Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Cognitive and Memory Enhancer Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Cognitive and Memory Enhancer Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Cognitive and Memory Enhancer Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Cognitive and Memory Enhancer Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Cognitive and Memory Enhancer Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Cognitive and Memory Enhancer Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Cognitive and Memory Enhancer Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Cognitive and Memory Enhancer Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Cognitive and Memory Enhancer Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Cognitive and Memory Enhancer Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Cognitive and Memory Enhancer Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Cognitive and Memory Enhancer Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Cognitive and Memory Enhancer Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Cognitive and Memory Enhancer Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Cognitive and Memory Enhancer Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Cognitive and Memory Enhancer Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Cognitive and Memory Enhancer Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cognitive and Memory Enhancer Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Cognitive and Memory Enhancer Drugs Market Segments
Table 2. Ranking of Global Top Cognitive and Memory Enhancer Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Aricept
Table 5. Major Manufacturers of Exelon
Table 6. Major Manufacturers of Namenda
Table 7. Major Manufacturers of Razadyne
Table 8. Major Manufacturers of Provigil
Table 9. Major Manufacturers of Ritalin
Table 10. Major Manufacturers of Adderall
Table 11. Major Manufacturers of Others
Table 12. Global Cognitive and Memory Enhancer Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Cognitive and Memory Enhancer Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Cognitive and Memory Enhancer Drugs Sales by Regions 2015-2020 (K Units)
Table 15. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Regions (2015-2020)
Table 16. Global Cognitive and Memory Enhancer Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Cognitive and Memory Enhancer Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Cognitive and Memory Enhancer Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Global Cognitive and Memory Enhancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Cognitive and Memory Enhancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cognitive and Memory Enhancer Drugs as of 2019)
Table 21. Cognitive and Memory Enhancer Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Cognitive and Memory Enhancer Drugs Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Cognitive and Memory Enhancer Drugs Price (2015-2020) (USD/Unit)
Table 24. Cognitive and Memory Enhancer Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Cognitive and Memory Enhancer Drugs Product Type
Table 26. Date of International Manufacturers Enter into Cognitive and Memory Enhancer Drugs Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Cognitive and Memory Enhancer Drugs Sales by Type (2015-2020) (K Units)
Table 29. Global Cognitive and Memory Enhancer Drugs Sales Share by Type (2015-2020)
Table 30. Global Cognitive and Memory Enhancer Drugs Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Cognitive and Memory Enhancer Drugs Revenue Share by Type (2015-2020)
Table 32. Cognitive and Memory Enhancer Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Cognitive and Memory Enhancer Drugs Sales by Application (2015-2020) (K Units)
Table 34. Global Cognitive and Memory Enhancer Drugs Sales Share by Application (2015-2020)
Table 35. North America Cognitive and Memory Enhancer Drugs Sales by Country (2015-2020) (K Units)
Table 36. North America Cognitive and Memory Enhancer Drugs Sales Market Share by Country (2015-2020)
Table 37. North America Cognitive and Memory Enhancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Cognitive and Memory Enhancer Drugs Revenue Market Share by Country (2015-2020)
Table 39. North America Cognitive and Memory Enhancer Drugs Sales by Type (2015-2020) (K Units)
Table 40. North America Cognitive and Memory Enhancer Drugs Sales Market Share by Type (2015-2020)
Table 41. North America Cognitive and Memory Enhancer Drugs Sales by Application (2015-2020) (K Units)
Table 42. North America Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2015-2020)
Table 43. Europe Cognitive and Memory Enhancer Drugs Sales by Country (2015-2020) (K Units)
Table 44. Europe Cognitive and Memory Enhancer Drugs Sales Market Share by Country (2015-2020)
Table 45. Europe Cognitive and Memory Enhancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Cognitive and Memory Enhancer Drugs Revenue Market Share by Country (2015-2020)
Table 47. Europe Cognitive and Memory Enhancer Drugs Sales by Type (2015-2020) (K Units)
Table 48. Europe Cognitive and Memory Enhancer Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Cognitive and Memory Enhancer Drugs Sales by Application (2015-2020) (K Units)
Table 50. Europe Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Cognitive and Memory Enhancer Drugs Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Cognitive and Memory Enhancer Drugs Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Cognitive and Memory Enhancer Drugs Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Cognitive and Memory Enhancer Drugs Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Cognitive and Memory Enhancer Drugs Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Cognitive and Memory Enhancer Drugs Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Cognitive and Memory Enhancer Drugs Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2015-2020)
Table 59. Latin America Cognitive and Memory Enhancer Drugs Sales by Country (2015-2020) (K Units)
Table 60. Latin America Cognitive and Memory Enhancer Drugs Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Cognitive and Memory Enhancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Cognitive and Memory Enhancer Drugs Revenue Market Share by Country (2015-2020)
Table 63. Latin America Cognitive and Memory Enhancer Drugs Sales by Type (2015-2020) (K Units)
Table 64. Latin America Cognitive and Memory Enhancer Drugs Sales Market Share by Type (2015-2020)
Table 65. Latin America Cognitive and Memory Enhancer Drugs Sales by Application (2015-2020) (K Units)
Table 66. Latin America Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Cognitive and Memory Enhancer Drugs Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Cognitive and Memory Enhancer Drugs Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Cognitive and Memory Enhancer Drugs Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Major Businesses
Table 77. Pfizer Cognitive and Memory Enhancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Pfizer Product
Table 79. Pfizer Recent Development
Table 80. Eisai Co Corporation Information
Table 81. Eisai Co Description and Major Businesses
Table 82. Eisai Co Cognitive and Memory Enhancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Eisai Co Product
Table 84. Eisai Co Recent Development
Table 85. Allergan Corporation Information
Table 86. Allergan Description and Major Businesses
Table 87. Allergan Cognitive and Memory Enhancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Allergan Product
Table 89. Allergan Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Major Businesses
Table 92. Novartis Cognitive and Memory Enhancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novartis Product
Table 94. Novartis Recent Development
Table 95. Takeda Corporation Information
Table 96. Takeda Description and Major Businesses
Table 97. Takeda Cognitive and Memory Enhancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Takeda Product
Table 99. Takeda Recent Development
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Major Businesses
Table 102. Johnson & Johnson Cognitive and Memory Enhancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Johnson & Johnson Product
Table 104. Johnson & Johnson Recent Development
Table 105. Takeda Pharmaceutical Company Limited Corporation Information
Table 106. Takeda Pharmaceutical Company Limited Description and Major Businesses
Table 107. Takeda Pharmaceutical Company Limited Cognitive and Memory Enhancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Takeda Pharmaceutical Company Limited Product
Table 109. Takeda Pharmaceutical Company Limited Recent Development
Table 110. AlternaScript Corporation Information
Table 111. AlternaScript Description and Major Businesses
Table 112. AlternaScript Cognitive and Memory Enhancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. AlternaScript Product
Table 114. AlternaScript Recent Development
Table 115. Cephalon Corporation Information
Table 116. Cephalon Description and Major Businesses
Table 117. Cephalon Cognitive and Memory Enhancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Cephalon Product
Table 119. Cephalon Recent Development
Table 120. Ceretropic Corporation Information
Table 121. Ceretropic Description and Major Businesses
Table 122. Ceretropic Cognitive and Memory Enhancer Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Ceretropic Product
Table 124. Ceretropic Recent Development
Table 125. Global Cognitive and Memory Enhancer Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 126. Global Cognitive and Memory Enhancer Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Cognitive and Memory Enhancer Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Cognitive and Memory Enhancer Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Cognitive and Memory Enhancer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 130. North America: Cognitive and Memory Enhancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Cognitive and Memory Enhancer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 132. Europe: Cognitive and Memory Enhancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Cognitive and Memory Enhancer Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 134. Asia Pacific: Cognitive and Memory Enhancer Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Cognitive and Memory Enhancer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 136. Latin America: Cognitive and Memory Enhancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Cognitive and Memory Enhancer Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 138. Middle East and Africa: Cognitive and Memory Enhancer Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Cognitive and Memory Enhancer Drugs Players
Table 143. Cognitive and Memory Enhancer Drugs Customers List
Table 144. Cognitive and Memory Enhancer Drugs Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Cognitive and Memory Enhancer Drugs Product Picture
Figure 2. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Aricept Product Picture
Figure 4. Exelon Product Picture
Figure 5. Namenda Product Picture
Figure 6. Razadyne Product Picture
Figure 7. Provigil Product Picture
Figure 8. Ritalin Product Picture
Figure 9. Adderall Product Picture
Figure 10. Others Product Picture
Figure 11. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Application in 2020 & 2026
Figure 12. Disease Treatment
Figure 13. Academic Performance
Figure 14. Athletic Performance
Figure 15. Others
Figure 16. Cognitive and Memory Enhancer Drugs Report Years Considered
Figure 17. Global Cognitive and Memory Enhancer Drugs Market Size 2015-2026 (US$ Million)
Figure 18. Global Cognitive and Memory Enhancer Drugs Sales 2015-2026 (K Units)
Figure 19. Global Cognitive and Memory Enhancer Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Region (2015-2020)
Figure 21. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Region in 2019
Figure 22. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Region (2015-2020)
Figure 23. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Region in 2019
Figure 24. Global Cognitive and Memory Enhancer Drugs Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by Cognitive and Memory Enhancer Drugs Revenue in 2019
Figure 26. Cognitive and Memory Enhancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Type (2015-2020)
Figure 28. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Type in 2019
Figure 29. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Type (2015-2020)
Figure 30. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Type in 2019
Figure 31. Global Cognitive and Memory Enhancer Drugs Market Share by Price Range (2015-2020)
Figure 32. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Application (2015-2020)
Figure 33. Global Cognitive and Memory Enhancer Drugs Sales Market Share by Application in 2019
Figure 34. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Application (2015-2020)
Figure 35. Global Cognitive and Memory Enhancer Drugs Revenue Market Share by Application in 2019
Figure 36. North America Cognitive and Memory Enhancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 37. North America Cognitive and Memory Enhancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Cognitive and Memory Enhancer Drugs Sales Market Share by Country in 2019
Figure 39. North America Cognitive and Memory Enhancer Drugs Revenue Market Share by Country in 2019
Figure 40. U.S. Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. U.S. Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Canada Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America Cognitive and Memory Enhancer Drugs Market Share by Type in 2019
Figure 45. North America Cognitive and Memory Enhancer Drugs Market Share by Application in 2019
Figure 46. Europe Cognitive and Memory Enhancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 47. Europe Cognitive and Memory Enhancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe Cognitive and Memory Enhancer Drugs Sales Market Share by Country in 2019
Figure 49. Europe Cognitive and Memory Enhancer Drugs Revenue Market Share by Country in 2019
Figure 50. Germany Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Germany Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. France Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. U.K. Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Italy Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. Russia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe Cognitive and Memory Enhancer Drugs Market Share by Type in 2019
Figure 61. Europe Cognitive and Memory Enhancer Drugs Market Share by Application in 2019
Figure 62. Asia Pacific Cognitive and Memory Enhancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 63. Asia Pacific Cognitive and Memory Enhancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific Cognitive and Memory Enhancer Drugs Sales Market Share by Region in 2019
Figure 65. Asia Pacific Cognitive and Memory Enhancer Drugs Revenue Market Share by Region in 2019
Figure 66. China Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. China Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Japan Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. South Korea Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. India Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Australia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Taiwan Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Indonesia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Thailand Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Malaysia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 85. Philippines Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 87. Vietnam Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific Cognitive and Memory Enhancer Drugs Market Share by Type in 2019
Figure 89. Asia Pacific Cognitive and Memory Enhancer Drugs Market Share by Application in 2019
Figure 90. Latin America Cognitive and Memory Enhancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 91. Latin America Cognitive and Memory Enhancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Cognitive and Memory Enhancer Drugs Sales Market Share by Country in 2019
Figure 93. Latin America Cognitive and Memory Enhancer Drugs Revenue Market Share by Country in 2019
Figure 94. Mexico Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 95. Mexico Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 97. Brazil Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 99. Argentina Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America Cognitive and Memory Enhancer Drugs Market Share by Type in 2019
Figure 101. Latin America Cognitive and Memory Enhancer Drugs Market Share by Application in 2019
Figure 102. Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 103. Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Market Share by Country in 2019
Figure 105. Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue Market Share by Country in 2019
Figure 106. Turkey Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 107. Turkey Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 109. Saudi Arabia Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E Cognitive and Memory Enhancer Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 111. U.A.E Cognitive and Memory Enhancer Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa Cognitive and Memory Enhancer Drugs Market Share by Type in 2019
Figure 113. Middle East and Africa Cognitive and Memory Enhancer Drugs Market Share by Application in 2019
Figure 114. North America Cognitive and Memory Enhancer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. North America Cognitive and Memory Enhancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Cognitive and Memory Enhancer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Europe Cognitive and Memory Enhancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Cognitive and Memory Enhancer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Asia Pacific Cognitive and Memory Enhancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Cognitive and Memory Enhancer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Latin America Cognitive and Memory Enhancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Cognitive and Memory Enhancer Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 123. Middle East and Africa Cognitive and Memory Enhancer Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
認知システムの世界市場（～2026年） Market Analysis and Insights: Global Cognitive Systems Market The global Cognitive Systems market size is projected to reach US$ 5 million by 2026, from US$ 4 million in 2020, at a CAGR of 11.5%% during 2021-2026. Global Cognitive Systems Scope and Market Size Cognitive Systems market is segmented b…- 医療用コグニティブコンピューティングの世界市場（～2026年） Cognitive computing (CC) describes technology platforms that are based on the scientific disciplines of artificial intelligence and signal processing. Key growth drivers include information explosion of structured and unstructured data, technological advancements in the field of data mining and anal…
- 認知症サプリメントの世界市場（～2026年） Cognitive supplements are balanced blends of herbal extracts and nutrients that are consumed to enhance brain functions such as concentration, mood, memory power, creativity and motivation in individuals. Market Analysis and Insights: Global Cognitive Supplements Market The global Cognitive Suppleme…
- コグニティブ無線の世界市場（～2026年） The cognitive radio market is segmented on the basis of components into software tools, hardware, and services. The software tools segment is expected to hold the largest market size during the forecast period. Software tools play an important role in the cognitive radio market. Components that are …
- 飲料エンハンサーの世界市場（～2026年） Market Analysis and Insights: Global Beverage Enhancer Market The global Beverage Enhancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Beverage Enhancer Scope and Market Size Beverage Enhancer market is segmented b…